Cann Group lights up medicinal cannabis market
Cann Group (ASX:CAN), a prominent player in the Australian medicinal cannabis industry, has announced its unaudited revenue results for the fiscal year 2023, showcasing remarkable growth. The company expects unaudited operating revenue of approximately $13.5 million, representing a substantial 111% increase compared to the previous fiscal year. This significant surge in revenue is driven by […]
Cann Group lights up medicinal cannabis market Read More »